Back to Search
Start Over
Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas.
- Source :
- Neuro-Oncology; Oct2023, Vol. 25 Issue 10, p1883-1894, 12p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 15228517
- Volume :
- 25
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Neuro-Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 172895719
- Full Text :
- https://doi.org/10.1093/neuonc/noad086